πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10842823

Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progeni

United Therapeutics Corporation Β· Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10844052

LLS compounds for treatment of cancer

The Regents of the University of California Β· Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10842835

Oncolytic vaccinia virus mutants and using same for cancer treatment

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10835755

Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10835513

Methods and treatments for the learning and memory deficits associated with Noonan syndrom

The Regents of the University of California Β· Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10822427

Anti-CSPG4 fusions with interferon for the treatment of malignancy

The Regents of the University of California Β· Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10815266

Ξ²-D-2β€²-deoxy-2β€²-Ξ±-fluoro-2β€²-Ξ²-C-substituted-2-modified-N6-substituted purine nucleotides f

Atea Pharmaceuticals, Inc. Β· Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10815285

Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neu

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10813918

Use of Gaboxadol in the treatment of diabetes and related conditions

OVID THERAPEUTICS INC. Β· Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10813899

Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related co

OVID THERAPEUTICS INC. Β· Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10813909

Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancre

The Regents of the University of California Β· Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10813917

Treatment methods utilizing stem cell mobilizers and immunosuppressive agents

MedRegen, LLC Β· Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10799485

Methods and compositions for treatment of epileptic disorders

OVID THERAPEUTICS INC. Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10799713

Miniature wearable laser treatment device

Veralase, LLC Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10799512

Estrogen combination for treatment of multiple sclerosis

The Regents of the University of California Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10799514

Non-hormonal steroid modulators of NF-kappa beta for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10799525

Composition of novel carbohydrate drug for treatment of human diseases

GALECTIN THERAPEUTICS, INC. Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10799559

NOPE for treatment of pathological muscle loss and weakness

Five Prime Therapeutics, Inc. Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10793547

Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compo

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10786501

Treatment of prostate cancer

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10786545

Use of peptides that block metadherin-SND1 interaction as treatment for cancer

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10780097

Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with gl

Corcept Therapeutics Incorporated Β· Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10772828

Controlled release antimicrobial compositions and methods for the treatment of otic disord

The Regents of the University of California Β· Granted Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10772865

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

Coherus BioSciences, Inc. Β· Granted Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted